- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin (glargine)
Total 2833 results
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Nordsjaellands HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedType 1 Diabetes Mellitus | Nocturnal Hypoglycemia | Recurrent Severe HypoglycaemiaDenmark
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Cliniques universitaires Saint-Luc- Université...CompletedType 1 DiabetesBelgium
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
AstraZenecaEli Lilly and CompanyCompleted
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedType 2 Diabetes MellitusCanada
-
Emory UniversityCompleted
-
SanofiCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
SanofiCompletedDiabetes Mellitus, Type 2France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
Rush University Medical CenterWithdrawn
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Riverside University Health System Medical CenterTerminated
-
Cairo UniversitySanofiUnknownLiver Cirrhosis | Type 2 DiabetesEgypt
-
Institut de Recherches Cliniques de MontrealNovo Nordisk A/S; McMaster UniversityCompleted
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
Vancouver General HospitalTerminatedPost-Transplant Glucocorticoid Induced DiabetesCanada
-
Assaf-Harofeh Medical CenterTerminated
-
University Hospital TuebingenWithdrawn
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedDiabetes MellitusSweden, Finland, Netherlands, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States
-
SanofiCompleted
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
University of Colorado, DenverCompletedType 1 Diabetes Mellitus | Diabetic KetoacidosisUnited States
-
Loyola UniversitySanofiCompletedRenal Insufficiency | Type 2 DiabetesUnited States
-
Dr. Muhammad AbdulghaniUnknown
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompleted
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Romania, Brazil, Czechia, Germany, Mexico, Argentina, Greece, Slovakia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany